AU2006218132B2 - Phosphate salts of 6-dimethylaminomethyl-l-(3-methoxyphenyl) -1,3-dihydroxycyclohexane compounds - Google Patents
Phosphate salts of 6-dimethylaminomethyl-l-(3-methoxyphenyl) -1,3-dihydroxycyclohexane compounds Download PDFInfo
- Publication number
- AU2006218132B2 AU2006218132B2 AU2006218132A AU2006218132A AU2006218132B2 AU 2006218132 B2 AU2006218132 B2 AU 2006218132B2 AU 2006218132 A AU2006218132 A AU 2006218132A AU 2006218132 A AU2006218132 A AU 2006218132A AU 2006218132 B2 AU2006218132 B2 AU 2006218132B2
- Authority
- AU
- Australia
- Prior art keywords
- polymorph
- dimethylaminomethyl
- methoxyphenyl
- cyclohexane
- approx
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005009217.9 | 2005-02-25 | ||
DE102005009217A DE102005009217A1 (de) | 2005-02-25 | 2005-02-25 | Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen |
PCT/EP2006/001547 WO2006089707A1 (de) | 2005-02-25 | 2006-02-21 | Phosphatsalze der 6-dimethylaminomethyl-l- (3-methoxyphenyl) -1,3-dihydroxy- cyclohexanverbindungen |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2006218132A1 AU2006218132A1 (en) | 2006-08-31 |
AU2006218132B2 true AU2006218132B2 (en) | 2011-10-06 |
Family
ID=36090780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2006218132A Ceased AU2006218132B2 (en) | 2005-02-25 | 2006-02-21 | Phosphate salts of 6-dimethylaminomethyl-l-(3-methoxyphenyl) -1,3-dihydroxycyclohexane compounds |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1851191A1 (zh) |
JP (1) | JP2008531510A (zh) |
KR (1) | KR20070107162A (zh) |
CN (1) | CN101137615A (zh) |
AR (1) | AR053145A1 (zh) |
AU (1) | AU2006218132B2 (zh) |
BR (1) | BRPI0606146A2 (zh) |
CA (1) | CA2598845A1 (zh) |
DE (1) | DE102005009217A1 (zh) |
IL (1) | IL185468A0 (zh) |
MX (1) | MX2007010361A (zh) |
NO (1) | NO20074673L (zh) |
NZ (1) | NZ556338A (zh) |
PE (1) | PE20061100A1 (zh) |
RU (1) | RU2007135271A (zh) |
TW (1) | TW200640840A (zh) |
WO (1) | WO2006089707A1 (zh) |
ZA (1) | ZA200708153B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007008752A2 (en) | 2005-07-07 | 2007-01-18 | Farnam Companies, Inc. | Sustained release pharmaceutical compositions for highly water soluble drugs |
DE102007022790A1 (de) * | 2007-05-11 | 2008-11-20 | Grünenthal GmbH | Axomadol zur Schmerzbehandlung bei Arthrose |
EP2477960A1 (en) * | 2009-09-14 | 2012-07-25 | Grünenthal GmbH | Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0753506A1 (de) * | 1995-07-11 | 1997-01-15 | Grünenthal GmbH | 6-dimethylaminomethyl-1-phenyl-cyclo-hexanverbindungen als pharmazeutische Wirkstoffe |
US20040242617A1 (en) * | 2001-09-18 | 2004-12-02 | Gruenenthal Gmbh | Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
WO2005009329A2 (de) * | 2003-07-24 | 2005-02-03 | Grünenthal GmbH | 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung |
-
2005
- 2005-02-25 DE DE102005009217A patent/DE102005009217A1/de not_active Withdrawn
-
2006
- 2006-02-10 TW TW095104476A patent/TW200640840A/zh unknown
- 2006-02-21 RU RU2007135271/04A patent/RU2007135271A/ru not_active Application Discontinuation
- 2006-02-21 JP JP2007556542A patent/JP2008531510A/ja not_active Withdrawn
- 2006-02-21 WO PCT/EP2006/001547 patent/WO2006089707A1/de active Application Filing
- 2006-02-21 BR BRPI0606146-0A patent/BRPI0606146A2/pt not_active IP Right Cessation
- 2006-02-21 MX MX2007010361A patent/MX2007010361A/es not_active Application Discontinuation
- 2006-02-21 AU AU2006218132A patent/AU2006218132B2/en not_active Ceased
- 2006-02-21 EP EP06707123A patent/EP1851191A1/de not_active Withdrawn
- 2006-02-21 CN CNA2006800059649A patent/CN101137615A/zh active Pending
- 2006-02-21 KR KR1020077021974A patent/KR20070107162A/ko not_active Application Discontinuation
- 2006-02-21 CA CA002598845A patent/CA2598845A1/en not_active Abandoned
- 2006-02-21 NZ NZ556338A patent/NZ556338A/en not_active IP Right Cessation
- 2006-02-24 AR ARP060100684A patent/AR053145A1/es not_active Application Discontinuation
- 2006-02-27 PE PE2006000228A patent/PE20061100A1/es not_active Application Discontinuation
-
2007
- 2007-08-23 IL IL185468A patent/IL185468A0/en unknown
- 2007-09-13 NO NO20074673A patent/NO20074673L/no not_active Application Discontinuation
- 2007-09-21 ZA ZA200708153A patent/ZA200708153B/xx unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0753506A1 (de) * | 1995-07-11 | 1997-01-15 | Grünenthal GmbH | 6-dimethylaminomethyl-1-phenyl-cyclo-hexanverbindungen als pharmazeutische Wirkstoffe |
USRE37355E1 (en) * | 1995-07-11 | 2001-09-04 | Gruenenthal Gmbh | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
US20040242617A1 (en) * | 2001-09-18 | 2004-12-02 | Gruenenthal Gmbh | Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
WO2005009329A2 (de) * | 2003-07-24 | 2005-02-03 | Grünenthal GmbH | 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung |
Also Published As
Publication number | Publication date |
---|---|
BRPI0606146A2 (pt) | 2009-06-02 |
CA2598845A1 (en) | 2006-08-31 |
CN101137615A (zh) | 2008-03-05 |
NZ556338A (en) | 2009-11-27 |
TW200640840A (en) | 2006-12-01 |
WO2006089707A1 (de) | 2006-08-31 |
AR053145A1 (es) | 2007-04-25 |
EP1851191A1 (de) | 2007-11-07 |
MX2007010361A (es) | 2008-02-21 |
KR20070107162A (ko) | 2007-11-06 |
PE20061100A1 (es) | 2007-01-04 |
AU2006218132A1 (en) | 2006-08-31 |
RU2007135271A (ru) | 2010-02-27 |
IL185468A0 (en) | 2008-01-06 |
ZA200708153B (en) | 2008-10-29 |
JP2008531510A (ja) | 2008-08-14 |
DE102005009217A1 (de) | 2006-08-31 |
NO20074673L (no) | 2007-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220024967A1 (en) | Salts and crystal forms of gaba-a positive allosteric modulator | |
NO326148B1 (no) | Tartratsalter av 5,8,14-triazatetracyklo (10.3.1.0<O>2,11</O>.0<O>4.9</O>)-heksadeka-2 (11),3,5,7,9-pentaen, samt anvendelse derav og farmasoytisk blanding derav | |
DK2240431T3 (en) | CRYSTALLIC MODIFICATION OF (1R, 2R) -3- (3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL) -PHENOL | |
JP2008239629A (ja) | 新規なベンラファクシン塩酸塩多型形状、ならびにその調製方法 | |
JP2021527043A (ja) | 新規の塩および結晶 | |
CN108290853B (zh) | 烟曲霉醇衍生物及其多晶型物 | |
JP2011530487A (ja) | バリオールアミンの立体選択的合成を行うための物質及び方法 | |
AU2006218132B2 (en) | Phosphate salts of 6-dimethylaminomethyl-l-(3-methoxyphenyl) -1,3-dihydroxycyclohexane compounds | |
US20100222602A1 (en) | Crystalline rotigotine base and preparation process therefor | |
US20130303786A1 (en) | Benzylpiperizine compound | |
US20060211887A1 (en) | Phosphate salts of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexane compounds | |
US20100256394A1 (en) | Method for the preparation of lasofoxifene | |
EP1701932A1 (en) | Tolterodine, compositions and uses thereof, and preparation of the same | |
BRPI0614395A2 (pt) | método de obter carbamatos de fenila | |
US20240010630A1 (en) | Salts of Obicetrapib and Processes for their Manufacture and Intermediates Thereof | |
WO2023064363A1 (en) | R-ketamine salts and methods of use thereof | |
EP3466923A1 (en) | Process for the preparation of agomelatine in crystalline form | |
CA3223576A1 (en) | Hydrogenated quinoxalines | |
CA1341011C (en) | Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1,2-diamine derivatives | |
CZ2012508A3 (cs) | Nový oxalát TAPENTADOLU a zpusob jeho prípravy | |
EP2539313A2 (en) | Crystal forms of o-desmethylvenlafaxine fumarate | |
JPS5892678A (ja) | ジオキサン系鎮痛剤の合成 | |
WO2007009793A1 (de) | Salz von fumarsäure und 3- (2-dimethylamino) methyl- ( cyclohex-1-yl) ) phenol un dessen kristalline formen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |